Franklin India Technology Fund-Growth vs ITI Pharma and Healthcare Fund - Direct Plan - Growth Option
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
Franklin India Technology Fund-Growth appears stronger overall due to its higher star rating of 5 compared to ITI Pharma and Healthcare Fund's rating of 2, indicating better historical performance and management quality. However, while Franklin India Technology Fund has a higher AUM of ₹1742 Cr, it also comes with a higher expense ratio of 1.16% compared to ITI Pharma and Healthcare Fund's 0.86%, which may impact net returns for investors. Ultimately, investors should consider whether they prioritize higher ratings and AUM or lower expenses when choosing between these funds.
Franklin India Technology Fund-Growth
Franklin Templeton Mutual Fund
★★★★★
Equity · Sectoral
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option
ITI Mutual Fund
★★★★★
Equity · Sectoral
| Metric | Franklin India Technol... | ITI Pharma and Healthc... |
|---|---|---|
| NAV | ₹544.36 | ₹20.08 |
| Star Rating | ★★★★★ | ★★ |
| Expense Ratio | 1.16% | 0.86% |
| AUM | ₹1,742 Cr | ₹266 Cr |
| 1M Return | +5.45% | +3.25% |
| 3M Return | -0.29% | +0.89% |
| 6M Return | +13.03% | +11.28% |
| 1Y Return | -5.8% | +12.1% |
| 3Y CAGR | +10.29% | +20.85% |
| 5Y CAGR | +7.22% | — |
| Risk Level | — | — |
| Fund Manager | Anand Radhakrishnan, Srikesh Nair, Varun Sharma | Pradeep Gokhale |